Ovulation

Researchers found that women with type 2 diabetes who received at least two doses of GLP-1 receptor agonists had a 27% lower risk for developing new-onset uterine fibroids compared to those who use metformin or insulin.

Five tested at-home ovulation predictor kits had high accuracy and performed similarly despite wide price differences between kits, according to study findings published in Fertility and Sterility.